Medical update: Hormone receptor-positive metastatic breast cancer

Hormone receptor-positive metastatic breast cancers test positive for estrogen (ER-positive) or progesterone (PR-positive) receptors, or both, and often respond to anti-estrogen therapies. This session details FDA approved and pipeline hormonal therapies, targeted therapies, and chemotherapy regimens that are used in metastatic disease, as well as ways to manage common side effects.

[@lindamarsh3335]

Thank you for this great update. I am on Ibrance and letrozole, so really want to learn of all the other treatments as a backup. Please keep reporting on these Many thanks.

[@Kitty-lv7jk]

Are there any trials moving away from chemotherapy towards safer treatments? I did heard about nanotechnology targeting tumors without damaging tumorse.

[@deborahbalitang199]

I was diagnosed with Invasive Ductile Carcinoma, ER - , PR +, HER 2 -. Do you recommend hormonal therapy in my case?

[@LivingBeyondBC]

Thank you for your comment. Here is a link to more information about invasive ductal carcinoma www.lbbc.org/about-breast-cancer/types-breast-cancer and hormonal therapies www.lbbc.org/about-breast-cancer/treatments/hormonal-therapy on our website. Since we are unable to answer specific medical questions or provide medical consultation, we encourage you to speak to your team of providers to learn more and to get answers based on your unique medical situation. Thanks again for your comment and we hope this information is helpful to you.